Results 21 to 30 of about 162,947 (233)
Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles [PDF]
Solmaz Ghaffari1, Jaleh Varshosaz1, Afrooz Saadat2, Fatemeh Atyabi21Department of Pharmaceutics, Faculty of Pharmacy and Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; 2Department of Pharmaceutics,
Afrooz Saadat +3 more
core +1 more source
Fin reduction is a novel and unexpected teratogenic effect of amikacin-treated zebrafish embryos [PDF]
We used zebrafish as a model to assess amikacin-induced embryotoxicity. We exposed zebrafish embryos to amikacin, using different amikacin doses (0-10 ppm), durations (12-48 h), and onsets (0, 24, 48 hpf).
Chen, Y.H.; Tsai, I.T.; Wen, C.C.; Wang, Y.H.; Cheng, C.C.; Hu, S.C0; Chen, Y.H. +2 more
core +1 more source
Background: Even though nebulised administration of amikacin can achieve high epithelial lining fluid concentrations, this has not translated into improved patient outcomes in clinical trials.
Heffernan, AJ +8 more
core +1 more source
Late-Onset Meningitis due to <i>Serratia marcescens</i> in a Preterm Infant: A Rare Sporadic Case Report From a Cambodian NICU. [PDF]
ABSTRACT Late‐onset neonatal meningitis due to Serratia marcescens is an uncommon but potentially life‐threatening healthcare‐associated infection in NICUs. We report a sporadic case in a preterm infant who developed fever on Day 17 of life after a prolonged hospital stay for feeding difficulties and neonatal jaundice.
Seng B, Im S, Bin S.
europepmc +2 more sources
Amikacin-induced Fin Reduction is Mediated by Autophagy [PDF]
Despite its medical use, little is known about the mechanisms underlying amikacin-induced embryotoxicity, including fin reduction, in zebrafish. In this study, we examined the expression of well-known autophagy markers mTOR (target of rapamycin), atg10 ...
Tsai, I-Ting; Chen, Yau-Hung; Wang, Yun-Hsin +1 more
core +1 more source
The comparative outcomes of specific aminoglycosides in cavitary type (fibrocavitary or cavitary nodular bronchiectatic type) Mycobacterium avium complex (MAC) pulmonary disease (PD) are unelucidated.
Seong Min Kim +4 more
doaj +1 more source
This study aims to compare the bacterial killing of once- versus twice-daily nebulized amikacin against Pseudomonas aeruginosa and to determine the optimal duration of therapy. Three clinical P.
Heffernan, AJ +9 more
core +1 more source
The rapid increase of carbapenem resistance in Gram-negative bacteria has resurrected the importance of the polymyxin antibiotics. The recent discovery of plasmid-mediated polymyxin resistance (mcr-1) in carbapenem-resistant Enterobacteriaceae serves as ...
Zackery P. Bulman +11 more
doaj +1 more source
Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics against Pseudomonas aeruginosa infections. Data from in vitro assays of CZA combinations, however, are scarce. The objective of our study was to perform a time-
María M. Montero +12 more
doaj +1 more source
Carvacrol attenuates amikacin-induced nephrotoxicity in the rats
Objective: Amikacin (AK) is a wide-spectrum antibiotic routinely used to treat gram-negative and some gram-positive bacterial infections. However, its use is limited due to its potential to cause nephrotoxicity due to an increase in reactive oxygen ...
Cemil Çolak +9 more
doaj +1 more source

